Latest Headlines
-
Bruker Applied Mass Spectrometry Showcases Front-Line Chromatography-Free MS Screening At SOFT 2025
10/29/2025
Bruker Applied Mass Spectrometry will highlight advances in harmonized sample preparation for chromatography-free forensic screening across oral fluid, urine, and blood at the Annual Meeting of the Society of Forensic Toxicologists (SOFT) 2025 in Portland, demonstrating DART-MS technology on the EVOQ DART-TQ⁺ system.
-
Monarch Diagnostics Launches New Clinical Lab In Dallas, Expanding Services To Texas
10/29/2025
Monarch Diagnostics today announced the opening of its newest full-service clinical laboratory in Dallas, Texas.
-
Roche Receives CE Mark For Novel Automated High-Throughput Elecsys Dengue Ag Test To Diagnose Dengue
10/29/2025
Roche announced today that it has received CE mark for its Elecsys Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection.
-
Noul Supplies AI Diagnostic Platform miLab™ To Charité, Europe's Leading University Hospital
10/28/2025
Noul Co., Ltd.(CEO David Lim), an AI-driven blood and cancer diagnostics company, announced the supply of its AI-based malaria diagnostic solution miLab™ MAL to Charité – Universitätsmedizin Berlin, Germany's largest and most prestigious university hospital.
-
Cepheid Announces World Health Organization Prequalification Of The Xpert® MTB/XDR Test
10/28/2025
Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new milestone in the global fight against tuberculosis (TB).
-
InstantGMP Launches Fully Integrated Laboratory Information Management System (LIMS) Software
10/28/2025
InstantGMP™, the innovators in manufacturing and quality management software for the pharmaceutical, supplement, and biotech industries, today announced the release of its new Laboratory Information Management System (LIMS), a fully integrated quality control (QC) module built directly into the InstantGMP manufacturing platform.
-
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership In Automated Sample Processing
10/28/2025
QIAGEN today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.
-
Simple Saliva Test Could Revolutionise Heart Failure Detection
10/27/2025
Detecting acute heart failure in the future could be as simple as testing a saliva sample.
-
Expanded Cap Carrier Range Improves Sample Management Flexibility
10/27/2025
Azenta Life Sciences has introduced new 24- and 48-format cap carriers, alongside its existing 96-format solution, to provide researchers with scalable options to streamline sample tube processing workflows, across a wide range of applications.
-
Co-Diagnostics Signs Definitive Agreement With Arabian Eagle In The Kingdom Of Saudi Arabia To Establish CoMira Diagnostics And Localize Co-Dx™ PCR Platform Across The Middle East
10/27/2025
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a definitive agreement with Arabian Eagle Manufacturing ("Arabian Eagle"), a regional manufacturing and distribution company based in the Kingdom of Saudi Arabia ("KSA") to form a joint venture ("JV"), CoMira Diagnostics ("CoMira"), to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property, including the Company's upcoming Co-Dx™ PCR point-of-care platform*, within KSA and 18 other countries (the "Territory") throughout the Middle East and North Africa ("MENA").